Aveo Capital Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-895
Closed -$269K 238
2024
Q4
$269K Sell
895
-20
-2% -$6.99K 0.03% 303
2024
Q3
$372K Sell
915
-451
-33% -$165K 0.04% 245
2024
Q2
$439K Buy
1,366
+28
+2% +$9.1K 0.05% 208
2024
Q1
$412K Buy
1,338
+103
+8% +$31.5K 0.04% 244
2023
Q4
$334K Buy
1,235
+29
+2% +$7.17K 0.04% 256
2023
Q3
$297K Buy
1,206
+76
+7% +$20.8K 0.04% 265
2023
Q2
$343K Buy
1,130
+99
+10% +$27.5K 0.04% 260
2023
Q1
$272K Buy
1,031
+188
+22% +$47.8K 0.04% 278
2022
Q4
$202K Buy
+843
New +$189K 0.03% 321

Other funds holding HCA

Aveo Capital Partners's HCA Position: Q1 2025 in Review

Aveo Capital Partners sold out of HCA Healthcare (HCA) in Q1 2025, closing a stake of 895 shares — an estimated $269K sold.

Aveo Capital Partners first reported a position in HCA in Q4 2022 and held it in 9 quarters. The position peaked at $439K in Q2 2024. 1,225 funds tracked by Wall St. Rank hold HCA as of Q1 2025.

  • Aveo Capital Partners reported no remaining HCA Healthcare position as of Q1 2025 after selling out during the quarter.
  • Aveo Capital Partners sold 895 HCA Healthcare shares in Q1 2025, an estimated $269K.
  • Aveo Capital Partners first reported a position in HCA Healthcare in Q4 2022 and held it in 9 quarters.
  • Aveo Capital Partners's HCA Healthcare position peaked at $439K in Q2 2024.
  • 1,225 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2025.

Based on Aveo Capital Partners's 13F filing for Q1 2025, filed 12 May 2025.